Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia? Submitted by admin on Wed, 09/18/2013 - 10:34 Read more about Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia? Source Motley Fool Headline Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia? News Tags chronic lymphocytic leukemia Sanofi Campath GSK Arzerra Roche Rituxan ibrutinib Pharmacyclics obinutuzumab JNJ Genmab
What Does The FDA's Breakthrough Designation Mean For Investors? Submitted by admin on Mon, 08/26/2013 - 13:28 Read more about What Does The FDA's Breakthrough Designation Mean For Investors? Source Seeking Alpha Headline What Does The FDA's Breakthrough Designation Mean For Investors? News Tags FDA breakthrough therapies AbbVie Alexion Ariad Pharmaceuticals Biomarin Bristol-Myers Squibb SynaGeva BioPharma GSK JNJ Merck Novartis Pharmacyclics Pfizer Vertex Pharmaceuticals daratumumab ibrutinib Kalydeco lambrolizumab palbociclib LDK378 SD-101 obinutuzumab serelaxin asfotase alfa bimagrumab drisapersen sebelipase alfa